The firm received the CE IVD mark for Amplidiag Easy, an automated system that enables nucleic acid extraction and PCR setup directly from stool samples.
The agreement with PerkinElmer's Wallac Oy subsidiary will bring Mobidiag's real-time PCR-based gastrointestinal tests to a new market.
The deal will help the Finnish diagnostics company expand its offerings of PCR-based gastrointestinal diagnostic tests.
The deal is the latest in a series of such arrangements Mobidiag has inked for its Amplidiag diagnostic product line in recent months.
The deal marks the latest in a series of arrangements the company has signed for distribution of its Amplidiag products internationally.
The Finnish firm is hoping to finalize manufacturing, validation, and commercialization of its new sample-to-result infectious disease diagnostics platform.
The deal covers Mobidiag's line of PCR-based Amplidiag tests for gastrointestinal infections, as well as its automated Amplidiag Easy platform.
Under a four-year agreement, Unilabs will offer Mobidiag's Amplidiag products in Sweden and Norway.
The latest addition to the firm's qPCR-based Amplidiag line of tests detects H. pylori as well as that pathogen's resistance to clarithromycin.
The product introduction comes about two years after the company merged with AmpliDiag and Genewave.
In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.
The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.
A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.
Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.